Company: PSTV
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047698
Chunk: 151

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 151
---
Page

    Report of BDO USA, P.C., Independent Registered Public Accounting Firm (PCAOB ID#243)
    75

    Consolidated Balance Sheets as of December 31, 2024 and 2023
    77

    Consolidated Statements of Operations for the years ended December 31, 2024 and 2023
    78

    Consolidated Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2024 and 2023
    79

    Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023
    80

    Notes to Financial Statements
    81

Report of Independent Registered Public Accounting Firm

Shareholders and Board of Directors 

Plus Therapeutics, Inc. 

Houston, Texas 

Opinion on the Consolidated Financial StatementsWe have audited the accompanying consolidated balance sheets of Plus Therapeutics, Inc. (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of operations, stockholders’ equity (deficit), and cash flows for each of the years then ended and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Going Concern Uncertainty

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses and negative cash flows from operations that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and